nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—SH2B3—hypothyroidism	0.5	1	CbGaD
Pazopanib—SLCO1B1—Dextrothyroxine—hypothyroidism	0.0663	0.214	CbGbCtD
Pazopanib—SLCO1B1—Levothyroxine—hypothyroidism	0.0503	0.162	CbGbCtD
Pazopanib—SLCO1B1—Liothyronine—hypothyroidism	0.0503	0.162	CbGbCtD
Pazopanib—SLCO1B1—Liotrix—hypothyroidism	0.049	0.159	CbGbCtD
Pazopanib—CYP2C8—Levothyroxine—hypothyroidism	0.0213	0.0688	CbGbCtD
Pazopanib—CYP2C8—Liotrix—hypothyroidism	0.0208	0.0671	CbGbCtD
Pazopanib—ABCB1—Liothyronine—hypothyroidism	0.0144	0.0465	CbGbCtD
Pazopanib—ABCB1—Levothyroxine—hypothyroidism	0.0144	0.0465	CbGbCtD
Pazopanib—ABCB1—Liotrix—hypothyroidism	0.014	0.0454	CbGbCtD
Pazopanib—CYP3A4—Levothyroxine—hypothyroidism	0.00862	0.0279	CbGbCtD
Pazopanib—Intestinal perforation—Liotrix—hypothyroidism	0.00208	0.0471	CcSEcCtD
Pazopanib—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00182	0.0413	CcSEcCtD
Pazopanib—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00126	0.0284	CcSEcCtD
Pazopanib—Myocardial infarction—Liothyronine—hypothyroidism	0.00125	0.0283	CcSEcCtD
Pazopanib—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.000896	0.0203	CcSEcCtD
Pazopanib—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.000896	0.0203	CcSEcCtD
Pazopanib—Creatinine increased—Liotrix—hypothyroidism	0.000865	0.0196	CcSEcCtD
Pazopanib—Hypertension—Liothyronine—hypothyroidism	0.00086	0.0195	CcSEcCtD
Pazopanib—Cardiac failure—Dextrothyroxine—hypothyroidism	0.000832	0.0188	CcSEcCtD
Pazopanib—Cardiac failure—Levothyroxine—hypothyroidism	0.000832	0.0188	CcSEcCtD
Pazopanib—Blood urea increased—Liotrix—hypothyroidism	0.000777	0.0176	CcSEcCtD
Pazopanib—Dehydration—Levothyroxine—hypothyroidism	0.000755	0.0171	CcSEcCtD
Pazopanib—Dehydration—Dextrothyroxine—hypothyroidism	0.000755	0.0171	CcSEcCtD
Pazopanib—Cardiac failure congestive—Liotrix—hypothyroidism	0.000659	0.0149	CcSEcCtD
Pazopanib—Weight decreased—Dextrothyroxine—hypothyroidism	0.000635	0.0144	CcSEcCtD
Pazopanib—Weight decreased—Levothyroxine—hypothyroidism	0.000635	0.0144	CcSEcCtD
Pazopanib—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.000617	0.014	CcSEcCtD
Pazopanib—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.000617	0.014	CcSEcCtD
Pazopanib—Myocardial infarction—Levothyroxine—hypothyroidism	0.000614	0.0139	CcSEcCtD
Pazopanib—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.000614	0.0139	CcSEcCtD
Pazopanib—Cardiac failure—Liotrix—hypothyroidism	0.000612	0.0138	CcSEcCtD
Pazopanib—Cerebrovascular accident—Liotrix—hypothyroidism	0.00061	0.0138	CcSEcCtD
Pazopanib—Blood creatinine increased—Liotrix—hypothyroidism	0.00056	0.0127	CcSEcCtD
Pazopanib—Dehydration—Liotrix—hypothyroidism	0.000556	0.0126	CcSEcCtD
Pazopanib—Flushing—Dextrothyroxine—hypothyroidism	0.000522	0.0118	CcSEcCtD
Pazopanib—Flushing—Levothyroxine—hypothyroidism	0.000522	0.0118	CcSEcCtD
Pazopanib—Abdominal distension—Liotrix—hypothyroidism	0.00052	0.0118	CcSEcCtD
Pazopanib—Alopecia—Dextrothyroxine—hypothyroidism	0.000497	0.0112	CcSEcCtD
Pazopanib—Alopecia—Levothyroxine—hypothyroidism	0.000497	0.0112	CcSEcCtD
Pazopanib—Weight decreased—Liotrix—hypothyroidism	0.000467	0.0106	CcSEcCtD
Pazopanib—Acute coronary syndrome—Liotrix—hypothyroidism	0.000454	0.0103	CcSEcCtD
Pazopanib—Myocardial infarction—Liotrix—hypothyroidism	0.000451	0.0102	CcSEcCtD
Pazopanib—Arthralgia—Levothyroxine—hypothyroidism	0.000416	0.00942	CcSEcCtD
Pazopanib—Arthralgia—Dextrothyroxine—hypothyroidism	0.000416	0.00942	CcSEcCtD
Pazopanib—Hypoaesthesia—Liotrix—hypothyroidism	0.000411	0.0093	CcSEcCtD
Pazopanib—Shock—Dextrothyroxine—hypothyroidism	0.000393	0.00888	CcSEcCtD
Pazopanib—Shock—Levothyroxine—hypothyroidism	0.000393	0.00888	CcSEcCtD
Pazopanib—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000386	0.00873	CcSEcCtD
Pazopanib—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000386	0.00873	CcSEcCtD
Pazopanib—Flushing—Liotrix—hypothyroidism	0.000384	0.00868	CcSEcCtD
Pazopanib—AURKC—testis—hypothyroidism	0.000373	0.00384	CbGeAlD
Pazopanib—LIMK2—pituitary gland—hypothyroidism	0.000373	0.00384	CbGeAlD
Pazopanib—TAOK1—cerebellum—hypothyroidism	0.000371	0.00382	CbGeAlD
Pazopanib—RIOK2—thyroid gland—hypothyroidism	0.00037	0.00381	CbGeAlD
Pazopanib—BMPR1B—thyroid gland—hypothyroidism	0.000366	0.00377	CbGeAlD
Pazopanib—Alopecia—Liotrix—hypothyroidism	0.000365	0.00826	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000364	0.00823	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000364	0.00823	CcSEcCtD
Pazopanib—STK16—female gonad—hypothyroidism	0.000363	0.00374	CbGeAlD
Pazopanib—Insomnia—Dextrothyroxine—hypothyroidism	0.000361	0.00817	CcSEcCtD
Pazopanib—Insomnia—Levothyroxine—hypothyroidism	0.000361	0.00817	CcSEcCtD
Pazopanib—SH2B3—liver—hypothyroidism	0.000358	0.00369	CbGeAlD
Pazopanib—RIOK2—female gonad—hypothyroidism	0.000357	0.00368	CbGeAlD
Pazopanib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000356	0.00805	CcSEcCtD
Pazopanib—Dyspnoea—Levothyroxine—hypothyroidism	0.000356	0.00805	CcSEcCtD
Pazopanib—FGF1—heart—hypothyroidism	0.000356	0.00366	CbGeAlD
Pazopanib—Flatulence—Liotrix—hypothyroidism	0.000355	0.00802	CcSEcCtD
Pazopanib—BMPR1B—female gonad—hypothyroidism	0.000354	0.00364	CbGeAlD
Pazopanib—LCK—heart—hypothyroidism	0.000354	0.00364	CbGeAlD
Pazopanib—Dysgeusia—Liotrix—hypothyroidism	0.000352	0.00797	CcSEcCtD
Pazopanib—SH2B3—cerebellum—hypothyroidism	0.00035	0.0036	CbGeAlD
Pazopanib—CYP3A4—urine—hypothyroidism	0.000348	0.00359	CbGeAlD
Pazopanib—STK36—adrenal gland—hypothyroidism	0.000344	0.00354	CbGeAlD
Pazopanib—Fatigue—Levothyroxine—hypothyroidism	0.000344	0.00779	CcSEcCtD
Pazopanib—Fatigue—Dextrothyroxine—hypothyroidism	0.000344	0.00779	CcSEcCtD
Pazopanib—STK36—blood—hypothyroidism	0.000344	0.00354	CbGeAlD
Pazopanib—CYP2D6—urine—hypothyroidism	0.000343	0.00353	CbGeAlD
Pazopanib—PIP4K2C—gonad—hypothyroidism	0.000341	0.00351	CbGeAlD
Pazopanib—PLK4—testis—hypothyroidism	0.000341	0.00351	CbGeAlD
Pazopanib—Vision blurred—Liotrix—hypothyroidism	0.000339	0.00767	CcSEcCtD
Pazopanib—PI4KB—adrenal gland—hypothyroidism	0.000339	0.00349	CbGeAlD
Pazopanib—PI4KB—blood—hypothyroidism	0.000339	0.00349	CbGeAlD
Pazopanib—FGF1—cardiovascular system—hypothyroidism	0.000336	0.00346	CbGeAlD
Pazopanib—PIP4K2C—pituitary gland—hypothyroidism	0.000333	0.00343	CbGeAlD
Pazopanib—LIMK2—adrenal gland—hypothyroidism	0.000333	0.00343	CbGeAlD
Pazopanib—LIMK2—blood—hypothyroidism	0.000333	0.00343	CbGeAlD
Pazopanib—STK36—thyroid gland—hypothyroidism	0.000332	0.00342	CbGeAlD
Pazopanib—FGFR1—pituitary gland—hypothyroidism	0.00033	0.0034	CbGeAlD
Pazopanib—PI4KB—thyroid gland—hypothyroidism	0.000327	0.00337	CbGeAlD
Pazopanib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000326	0.00738	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000326	0.00738	CcSEcCtD
Pazopanib—MAP3K2—gonad—hypothyroidism	0.000324	0.00333	CbGeAlD
Pazopanib—Syncope—Liotrix—hypothyroidism	0.000323	0.0073	CcSEcCtD
Pazopanib—FLT1—adrenal cortex—hypothyroidism	0.000322	0.00332	CbGeAlD
Pazopanib—STK16—testis—hypothyroidism	0.000322	0.00332	CbGeAlD
Pazopanib—LIMK2—thyroid gland—hypothyroidism	0.000321	0.00331	CbGeAlD
Pazopanib—STK36—female gonad—hypothyroidism	0.000321	0.00331	CbGeAlD
Pazopanib—FGFR2—cardiovascular system—hypothyroidism	0.000317	0.00327	CbGeAlD
Pazopanib—FGFR3—testis—hypothyroidism	0.000317	0.00326	CbGeAlD
Pazopanib—RIOK2—testis—hypothyroidism	0.000317	0.00326	CbGeAlD
Pazopanib—Loss of consciousness—Liotrix—hypothyroidism	0.000316	0.00715	CcSEcCtD
Pazopanib—PI4KB—female gonad—hypothyroidism	0.000316	0.00325	CbGeAlD
Pazopanib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000316	0.00714	CcSEcCtD
Pazopanib—Abdominal pain—Levothyroxine—hypothyroidism	0.000316	0.00714	CcSEcCtD
Pazopanib—BMPR1B—testis—hypothyroidism	0.000314	0.00323	CbGeAlD
Pazopanib—MAP3K19—testis—hypothyroidism	0.000314	0.00323	CbGeAlD
Pazopanib—FLT1—heart—hypothyroidism	0.000312	0.00321	CbGeAlD
Pazopanib—Hypertension—Liotrix—hypothyroidism	0.000311	0.00703	CcSEcCtD
Pazopanib—LIMK2—female gonad—hypothyroidism	0.00031	0.0032	CbGeAlD
Pazopanib—EPHB6—heart—hypothyroidism	0.000308	0.00317	CbGeAlD
Pazopanib—Chest pain—Liotrix—hypothyroidism	0.000306	0.00693	CcSEcCtD
Pazopanib—Arthralgia—Liotrix—hypothyroidism	0.000306	0.00693	CcSEcCtD
Pazopanib—STK16—liver—hypothyroidism	0.000304	0.00313	CbGeAlD
Pazopanib—TAOK3—adrenal cortex—hypothyroidism	0.000304	0.00313	CbGeAlD
Pazopanib—LYN—liver—hypothyroidism	0.000301	0.0031	CbGeAlD
Pazopanib—RIOK2—liver—hypothyroidism	0.0003	0.00309	CbGeAlD
Pazopanib—FGFR3—liver—hypothyroidism	0.0003	0.00309	CbGeAlD
Pazopanib—FLT4—adrenal gland—hypothyroidism	0.000299	0.00308	CbGeAlD
Pazopanib—FLT4—blood—hypothyroidism	0.000299	0.00308	CbGeAlD
Pazopanib—PIP4K2C—adrenal gland—hypothyroidism	0.000297	0.00306	CbGeAlD
Pazopanib—PIP4K2C—blood—hypothyroidism	0.000297	0.00306	CbGeAlD
Pazopanib—FGF1—pituitary gland—hypothyroidism	0.000297	0.00306	CbGeAlD
Pazopanib—STK16—cerebellum—hypothyroidism	0.000297	0.00306	CbGeAlD
Pazopanib—FGFR1—adrenal gland—hypothyroidism	0.000295	0.00304	CbGeAlD
Pazopanib—STK10—heart—hypothyroidism	0.000295	0.00304	CbGeAlD
Pazopanib—FLT1—cardiovascular system—hypothyroidism	0.000294	0.00303	CbGeAlD
Pazopanib—TAOK3—heart—hypothyroidism	0.000294	0.00303	CbGeAlD
Pazopanib—Oedema—Liotrix—hypothyroidism	0.000294	0.00664	CcSEcCtD
Pazopanib—FGFR3—cerebellum—hypothyroidism	0.000293	0.00301	CbGeAlD
Pazopanib—RIOK2—cerebellum—hypothyroidism	0.000293	0.00301	CbGeAlD
Pazopanib—PDGFRA—heart—hypothyroidism	0.000292	0.00301	CbGeAlD
Pazopanib—Infection—Liotrix—hypothyroidism	0.000292	0.0066	CcSEcCtD
Pazopanib—BMPR1B—cerebellum—hypothyroidism	0.00029	0.00298	CbGeAlD
Pazopanib—Shock—Liotrix—hypothyroidism	0.000289	0.00654	CcSEcCtD
Pazopanib—FLT4—thyroid gland—hypothyroidism	0.000289	0.00297	CbGeAlD
Pazopanib—PIP4K2C—thyroid gland—hypothyroidism	0.000287	0.00296	CbGeAlD
Pazopanib—Asthenia—Levothyroxine—hypothyroidism	0.000286	0.00648	CcSEcCtD
Pazopanib—Asthenia—Dextrothyroxine—hypothyroidism	0.000286	0.00648	CcSEcCtD
Pazopanib—FGFR1—thyroid gland—hypothyroidism	0.000285	0.00293	CbGeAlD
Pazopanib—STK36—testis—hypothyroidism	0.000285	0.00293	CbGeAlD
Pazopanib—Hyperhidrosis—Liotrix—hypothyroidism	0.000284	0.00642	CcSEcCtD
Pazopanib—Pruritus—Levothyroxine—hypothyroidism	0.000282	0.00639	CcSEcCtD
Pazopanib—Pruritus—Dextrothyroxine—hypothyroidism	0.000282	0.00639	CcSEcCtD
Pazopanib—MAP3K2—adrenal gland—hypothyroidism	0.000282	0.0029	CbGeAlD
Pazopanib—MAP3K2—blood—hypothyroidism	0.000282	0.0029	CbGeAlD
Pazopanib—PI4KB—testis—hypothyroidism	0.00028	0.00289	CbGeAlD
Pazopanib—Anorexia—Liotrix—hypothyroidism	0.00028	0.00633	CcSEcCtD
Pazopanib—FLT4—female gonad—hypothyroidism	0.000279	0.00287	CbGeAlD
Pazopanib—STK10—cardiovascular system—hypothyroidism	0.000278	0.00287	CbGeAlD
Pazopanib—PIP4K2C—female gonad—hypothyroidism	0.000277	0.00286	CbGeAlD
Pazopanib—TAOK3—cardiovascular system—hypothyroidism	0.000277	0.00285	CbGeAlD
Pazopanib—PDGFRA—cardiovascular system—hypothyroidism	0.000275	0.00284	CbGeAlD
Pazopanib—LIMK2—testis—hypothyroidism	0.000275	0.00283	CbGeAlD
Pazopanib—FGFR1—female gonad—hypothyroidism	0.000275	0.00283	CbGeAlD
Pazopanib—Diarrhoea—Levothyroxine—hypothyroidism	0.000273	0.00618	CcSEcCtD
Pazopanib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000273	0.00618	CcSEcCtD
Pazopanib—KDR—adrenal cortex—hypothyroidism	0.000272	0.0028	CbGeAlD
Pazopanib—MAP2K5—adrenal cortex—hypothyroidism	0.000272	0.0028	CbGeAlD
Pazopanib—MAP3K2—thyroid gland—hypothyroidism	0.000272	0.0028	CbGeAlD
Pazopanib—STK36—liver—hypothyroidism	0.000269	0.00277	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000268	0.00605	CcSEcCtD
Pazopanib—FLT1—gonad—hypothyroidism	0.000267	0.00275	CbGeAlD
Pazopanib—CSF1R—adrenal cortex—hypothyroidism	0.000266	0.00274	CbGeAlD
Pazopanib—FGF1—adrenal gland—hypothyroidism	0.000266	0.00274	CbGeAlD
Pazopanib—Insomnia—Liotrix—hypothyroidism	0.000266	0.00601	CcSEcCtD
Pazopanib—FGF1—blood—hypothyroidism	0.000266	0.00273	CbGeAlD
Pazopanib—PI4KB—liver—hypothyroidism	0.000265	0.00273	CbGeAlD
Pazopanib—LCK—adrenal gland—hypothyroidism	0.000264	0.00272	CbGeAlD
Pazopanib—LCK—blood—hypothyroidism	0.000264	0.00272	CbGeAlD
Pazopanib—Paraesthesia—Liotrix—hypothyroidism	0.000264	0.00596	CcSEcCtD
Pazopanib—KDR—heart—hypothyroidism	0.000263	0.00271	CbGeAlD
Pazopanib—MAP2K5—heart—hypothyroidism	0.000263	0.00271	CbGeAlD
Pazopanib—STK36—cerebellum—hypothyroidism	0.000263	0.00271	CbGeAlD
Pazopanib—MAP3K2—female gonad—hypothyroidism	0.000263	0.00271	CbGeAlD
Pazopanib—Dyspnoea—Liotrix—hypothyroidism	0.000262	0.00592	CcSEcCtD
Pazopanib—FLT1—pituitary gland—hypothyroidism	0.00026	0.00268	CbGeAlD
Pazopanib—LIMK2—liver—hypothyroidism	0.00026	0.00268	CbGeAlD
Pazopanib—PI4KB—cerebellum—hypothyroidism	0.000259	0.00267	CbGeAlD
Pazopanib—EPHB6—pituitary gland—hypothyroidism	0.000257	0.00265	CbGeAlD
Pazopanib—CSF1R—heart—hypothyroidism	0.000257	0.00265	CbGeAlD
Pazopanib—FGF1—thyroid gland—hypothyroidism	0.000256	0.00264	CbGeAlD
Pazopanib—Decreased appetite—Liotrix—hypothyroidism	0.000255	0.00577	CcSEcCtD
Pazopanib—LCK—thyroid gland—hypothyroidism	0.000255	0.00262	CbGeAlD
Pazopanib—LIMK2—cerebellum—hypothyroidism	0.000254	0.00262	CbGeAlD
Pazopanib—Vomiting—Levothyroxine—hypothyroidism	0.000254	0.00574	CcSEcCtD
Pazopanib—Vomiting—Dextrothyroxine—hypothyroidism	0.000254	0.00574	CcSEcCtD
Pazopanib—Fatigue—Liotrix—hypothyroidism	0.000253	0.00573	CcSEcCtD
Pazopanib—STK10—gonad—hypothyroidism	0.000253	0.0026	CbGeAlD
Pazopanib—Rash—Levothyroxine—hypothyroidism	0.000252	0.00569	CcSEcCtD
Pazopanib—Rash—Dextrothyroxine—hypothyroidism	0.000252	0.00569	CcSEcCtD
Pazopanib—Dermatitis—Levothyroxine—hypothyroidism	0.000252	0.00569	CcSEcCtD
Pazopanib—Dermatitis—Dextrothyroxine—hypothyroidism	0.000252	0.00569	CcSEcCtD
Pazopanib—FGFR2—adrenal gland—hypothyroidism	0.000251	0.00258	CbGeAlD
Pazopanib—FGFR2—blood—hypothyroidism	0.000251	0.00258	CbGeAlD
Pazopanib—Headache—Levothyroxine—hypothyroidism	0.00025	0.00566	CcSEcCtD
Pazopanib—Headache—Dextrothyroxine—hypothyroidism	0.00025	0.00566	CcSEcCtD
Pazopanib—PDGFRA—gonad—hypothyroidism	0.00025	0.00257	CbGeAlD
Pazopanib—KDR—cardiovascular system—hypothyroidism	0.000249	0.00256	CbGeAlD
Pazopanib—MAP2K5—cardiovascular system—hypothyroidism	0.000249	0.00256	CbGeAlD
Pazopanib—FGF1—female gonad—hypothyroidism	0.000248	0.00255	CbGeAlD
Pazopanib—FLT4—testis—hypothyroidism	0.000247	0.00255	CbGeAlD
Pazopanib—LCK—female gonad—hypothyroidism	0.000246	0.00254	CbGeAlD
Pazopanib—PIP4K2C—testis—hypothyroidism	0.000246	0.00253	CbGeAlD
Pazopanib—TAOK3—pituitary gland—hypothyroidism	0.000245	0.00253	CbGeAlD
Pazopanib—FGFR1—testis—hypothyroidism	0.000244	0.00251	CbGeAlD
Pazopanib—CSF1R—cardiovascular system—hypothyroidism	0.000243	0.0025	CbGeAlD
Pazopanib—FGFR2—thyroid gland—hypothyroidism	0.000242	0.00249	CbGeAlD
Pazopanib—Gastrointestinal pain—Liotrix—hypothyroidism	0.00024	0.00543	CcSEcCtD
Pazopanib—Nausea—Levothyroxine—hypothyroidism	0.000237	0.00536	CcSEcCtD
Pazopanib—Nausea—Dextrothyroxine—hypothyroidism	0.000237	0.00536	CcSEcCtD
Pazopanib—PDGFRB—adrenal cortex—hypothyroidism	0.000236	0.00243	CbGeAlD
Pazopanib—FGFR2—female gonad—hypothyroidism	0.000234	0.00241	CbGeAlD
Pazopanib—FLT4—liver—hypothyroidism	0.000234	0.00241	CbGeAlD
Pazopanib—KIT—heart—hypothyroidism	0.000233	0.0024	CbGeAlD
Pazopanib—MAP3K2—testis—hypothyroidism	0.000233	0.0024	CbGeAlD
Pazopanib—PIP4K2C—liver—hypothyroidism	0.000233	0.00239	CbGeAlD
Pazopanib—FLT1—adrenal gland—hypothyroidism	0.000233	0.00239	CbGeAlD
Pazopanib—FLT1—blood—hypothyroidism	0.000232	0.00239	CbGeAlD
Pazopanib—Abdominal pain—Liotrix—hypothyroidism	0.000232	0.00525	CcSEcCtD
Pazopanib—FGFR1—liver—hypothyroidism	0.000231	0.00238	CbGeAlD
Pazopanib—EPHB6—adrenal gland—hypothyroidism	0.00023	0.00237	CbGeAlD
Pazopanib—EPHB6—blood—hypothyroidism	0.00023	0.00237	CbGeAlD
Pazopanib—PDGFRB—heart—hypothyroidism	0.000228	0.00235	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—hypothyroidism	0.000227	0.00234	CbGeAlD
Pazopanib—FGFR1—cerebellum—hypothyroidism	0.000225	0.00232	CbGeAlD
Pazopanib—FLT1—thyroid gland—hypothyroidism	0.000224	0.00231	CbGeAlD
Pazopanib—EPHB6—thyroid gland—hypothyroidism	0.000222	0.00228	CbGeAlD
Pazopanib—MAP3K2—liver—hypothyroidism	0.00022	0.00227	CbGeAlD
Pazopanib—KIT—cardiovascular system—hypothyroidism	0.00022	0.00227	CbGeAlD
Pazopanib—STK10—adrenal gland—hypothyroidism	0.00022	0.00227	CbGeAlD
Pazopanib—CSF1R—gonad—hypothyroidism	0.00022	0.00227	CbGeAlD
Pazopanib—STK10—blood—hypothyroidism	0.00022	0.00227	CbGeAlD
Pazopanib—KDR—pituitary gland—hypothyroidism	0.00022	0.00227	CbGeAlD
Pazopanib—MAP2K5—pituitary gland—hypothyroidism	0.00022	0.00227	CbGeAlD
Pazopanib—FGF1—testis—hypothyroidism	0.00022	0.00226	CbGeAlD
Pazopanib—TAOK3—adrenal gland—hypothyroidism	0.000219	0.00226	CbGeAlD
Pazopanib—TAOK3—blood—hypothyroidism	0.000219	0.00226	CbGeAlD
Pazopanib—LCK—testis—hypothyroidism	0.000218	0.00225	CbGeAlD
Pazopanib—PDGFRA—adrenal gland—hypothyroidism	0.000218	0.00224	CbGeAlD
Pazopanib—PDGFRA—blood—hypothyroidism	0.000218	0.00224	CbGeAlD
Pazopanib—FLT1—female gonad—hypothyroidism	0.000217	0.00223	CbGeAlD
Pazopanib—MAP3K2—cerebellum—hypothyroidism	0.000215	0.00222	CbGeAlD
Pazopanib—PDGFRB—cardiovascular system—hypothyroidism	0.000215	0.00221	CbGeAlD
Pazopanib—CSF1R—pituitary gland—hypothyroidism	0.000215	0.00221	CbGeAlD
Pazopanib—EPHB6—female gonad—hypothyroidism	0.000214	0.00221	CbGeAlD
Pazopanib—STK10—thyroid gland—hypothyroidism	0.000212	0.00219	CbGeAlD
Pazopanib—TAOK3—thyroid gland—hypothyroidism	0.000212	0.00218	CbGeAlD
Pazopanib—Asthenia—Liotrix—hypothyroidism	0.000211	0.00477	CcSEcCtD
Pazopanib—PDGFRA—thyroid gland—hypothyroidism	0.00021	0.00217	CbGeAlD
Pazopanib—UGT1A1—blood—hypothyroidism	0.000208	0.00214	CbGeAlD
Pazopanib—Pruritus—Liotrix—hypothyroidism	0.000208	0.0047	CcSEcCtD
Pazopanib—FGF1—liver—hypothyroidism	0.000208	0.00214	CbGeAlD
Pazopanib—FGFR2—testis—hypothyroidism	0.000207	0.00214	CbGeAlD
Pazopanib—LCK—liver—hypothyroidism	0.000206	0.00213	CbGeAlD
Pazopanib—STK10—female gonad—hypothyroidism	0.000205	0.00211	CbGeAlD
Pazopanib—TAOK3—female gonad—hypothyroidism	0.000204	0.00211	CbGeAlD
Pazopanib—PDGFRA—female gonad—hypothyroidism	0.000203	0.00209	CbGeAlD
Pazopanib—FGF1—cerebellum—hypothyroidism	0.000203	0.00209	CbGeAlD
Pazopanib—Diarrhoea—Liotrix—hypothyroidism	0.000201	0.00454	CcSEcCtD
Pazopanib—KIT—gonad—hypothyroidism	0.0002	0.00206	CbGeAlD
Pazopanib—KDR—adrenal gland—hypothyroidism	0.000197	0.00202	CbGeAlD
Pazopanib—MAP2K5—adrenal gland—hypothyroidism	0.000197	0.00202	CbGeAlD
Pazopanib—MAP2K5—blood—hypothyroidism	0.000197	0.00202	CbGeAlD
Pazopanib—KDR—blood—hypothyroidism	0.000197	0.00202	CbGeAlD
Pazopanib—FGFR2—liver—hypothyroidism	0.000196	0.00202	CbGeAlD
Pazopanib—PDGFRB—gonad—hypothyroidism	0.000195	0.00201	CbGeAlD
Pazopanib—KIT—pituitary gland—hypothyroidism	0.000195	0.00201	CbGeAlD
Pazopanib—Dizziness—Liotrix—hypothyroidism	0.000194	0.00439	CcSEcCtD
Pazopanib—FLT1—testis—hypothyroidism	0.000192	0.00198	CbGeAlD
Pazopanib—CSF1R—adrenal gland—hypothyroidism	0.000192	0.00198	CbGeAlD
Pazopanib—CSF1R—blood—hypothyroidism	0.000192	0.00198	CbGeAlD
Pazopanib—FGFR2—cerebellum—hypothyroidism	0.000192	0.00197	CbGeAlD
Pazopanib—PDGFRB—pituitary gland—hypothyroidism	0.00019	0.00196	CbGeAlD
Pazopanib—EPHB6—testis—hypothyroidism	0.00019	0.00196	CbGeAlD
Pazopanib—KDR—thyroid gland—hypothyroidism	0.00019	0.00195	CbGeAlD
Pazopanib—MAP2K5—thyroid gland—hypothyroidism	0.00019	0.00195	CbGeAlD
Pazopanib—Vomiting—Liotrix—hypothyroidism	0.000187	0.00422	CcSEcCtD
Pazopanib—Rash—Liotrix—hypothyroidism	0.000185	0.00419	CcSEcCtD
Pazopanib—CSF1R—thyroid gland—hypothyroidism	0.000185	0.00191	CbGeAlD
Pazopanib—Dermatitis—Liotrix—hypothyroidism	0.000185	0.00418	CcSEcCtD
Pazopanib—Headache—Liotrix—hypothyroidism	0.000184	0.00416	CcSEcCtD
Pazopanib—KDR—female gonad—hypothyroidism	0.000183	0.00189	CbGeAlD
Pazopanib—MAP2K5—female gonad—hypothyroidism	0.000183	0.00189	CbGeAlD
Pazopanib—STK10—testis—hypothyroidism	0.000182	0.00187	CbGeAlD
Pazopanib—FLT1—liver—hypothyroidism	0.000182	0.00187	CbGeAlD
Pazopanib—TAOK3—testis—hypothyroidism	0.000181	0.00187	CbGeAlD
Pazopanib—PDGFRA—testis—hypothyroidism	0.00018	0.00186	CbGeAlD
Pazopanib—CSF1R—female gonad—hypothyroidism	0.000179	0.00184	CbGeAlD
Pazopanib—FLT1—cerebellum—hypothyroidism	0.000178	0.00183	CbGeAlD
Pazopanib—EPHB6—cerebellum—hypothyroidism	0.000176	0.00181	CbGeAlD
Pazopanib—Nausea—Liotrix—hypothyroidism	0.000174	0.00395	CcSEcCtD
Pazopanib—KIT—adrenal gland—hypothyroidism	0.000174	0.00179	CbGeAlD
Pazopanib—KIT—blood—hypothyroidism	0.000174	0.00179	CbGeAlD
Pazopanib—SLCO1B1—blood—hypothyroidism	0.000173	0.00178	CbGeAlD
Pazopanib—STK10—liver—hypothyroidism	0.000172	0.00177	CbGeAlD
Pazopanib—TAOK3—liver—hypothyroidism	0.000171	0.00177	CbGeAlD
Pazopanib—PDGFRA—liver—hypothyroidism	0.00017	0.00175	CbGeAlD
Pazopanib—PDGFRB—adrenal gland—hypothyroidism	0.00017	0.00175	CbGeAlD
Pazopanib—PDGFRB—blood—hypothyroidism	0.00017	0.00175	CbGeAlD
Pazopanib—STK10—cerebellum—hypothyroidism	0.000168	0.00173	CbGeAlD
Pazopanib—KIT—thyroid gland—hypothyroidism	0.000168	0.00173	CbGeAlD
Pazopanib—TAOK3—cerebellum—hypothyroidism	0.000167	0.00172	CbGeAlD
Pazopanib—PDGFRA—cerebellum—hypothyroidism	0.000166	0.00171	CbGeAlD
Pazopanib—PDGFRB—thyroid gland—hypothyroidism	0.000164	0.00169	CbGeAlD
Pazopanib—KDR—testis—hypothyroidism	0.000163	0.00167	CbGeAlD
Pazopanib—MAP2K5—testis—hypothyroidism	0.000163	0.00167	CbGeAlD
Pazopanib—UGT1A1—liver—hypothyroidism	0.000163	0.00167	CbGeAlD
Pazopanib—KIT—female gonad—hypothyroidism	0.000162	0.00167	CbGeAlD
Pazopanib—CSF1R—testis—hypothyroidism	0.000159	0.00163	CbGeAlD
Pazopanib—PDGFRB—female gonad—hypothyroidism	0.000159	0.00163	CbGeAlD
Pazopanib—KDR—liver—hypothyroidism	0.000154	0.00158	CbGeAlD
Pazopanib—MAP2K5—liver—hypothyroidism	0.000154	0.00158	CbGeAlD
Pazopanib—MAP2K5—cerebellum—hypothyroidism	0.00015	0.00155	CbGeAlD
Pazopanib—KDR—cerebellum—hypothyroidism	0.00015	0.00155	CbGeAlD
Pazopanib—CSF1R—liver—hypothyroidism	0.00015	0.00154	CbGeAlD
Pazopanib—CSF1R—cerebellum—hypothyroidism	0.000147	0.00151	CbGeAlD
Pazopanib—KIT—testis—hypothyroidism	0.000144	0.00148	CbGeAlD
Pazopanib—PDGFRB—testis—hypothyroidism	0.000141	0.00145	CbGeAlD
Pazopanib—KIT—liver—hypothyroidism	0.000136	0.0014	CbGeAlD
Pazopanib—SLCO1B1—liver—hypothyroidism	0.000135	0.00139	CbGeAlD
Pazopanib—KIT—cerebellum—hypothyroidism	0.000133	0.00137	CbGeAlD
Pazopanib—PDGFRB—liver—hypothyroidism	0.000133	0.00137	CbGeAlD
Pazopanib—ABCG2—adrenal cortex—hypothyroidism	0.000132	0.00136	CbGeAlD
Pazopanib—PDGFRB—cerebellum—hypothyroidism	0.00013	0.00134	CbGeAlD
Pazopanib—ABCG2—heart—hypothyroidism	0.000128	0.00132	CbGeAlD
Pazopanib—CYP2C8—pituitary gland—hypothyroidism	0.00011	0.00113	CbGeAlD
Pazopanib—ABCG2—pituitary gland—hypothyroidism	0.000107	0.0011	CbGeAlD
Pazopanib—CYP2C8—blood—hypothyroidism	9.83e-05	0.00101	CbGeAlD
Pazopanib—ABCG2—adrenal gland—hypothyroidism	9.56e-05	0.000985	CbGeAlD
Pazopanib—ABCG2—blood—hypothyroidism	9.56e-05	0.000985	CbGeAlD
Pazopanib—ABCG2—thyroid gland—hypothyroidism	9.23e-05	0.00095	CbGeAlD
Pazopanib—CYP1A2—blood—hypothyroidism	9.2e-05	0.000948	CbGeAlD
Pazopanib—ABCG2—female gonad—hypothyroidism	8.92e-05	0.000918	CbGeAlD
Pazopanib—CYP1A2—thyroid gland—hypothyroidism	8.88e-05	0.000915	CbGeAlD
Pazopanib—CYP2C8—testis—hypothyroidism	8.13e-05	0.000838	CbGeAlD
Pazopanib—ABCG2—testis—hypothyroidism	7.91e-05	0.000814	CbGeAlD
Pazopanib—CYP2C8—liver—hypothyroidism	7.69e-05	0.000792	CbGeAlD
Pazopanib—ABCG2—liver—hypothyroidism	7.48e-05	0.00077	CbGeAlD
Pazopanib—ABCG2—cerebellum—hypothyroidism	7.3e-05	0.000752	CbGeAlD
Pazopanib—CYP1A2—liver—hypothyroidism	7.2e-05	0.000741	CbGeAlD
Pazopanib—CYP3A4—blood—hypothyroidism	6.66e-05	0.000686	CbGeAlD
Pazopanib—CYP2D6—blood—hypothyroidism	6.55e-05	0.000675	CbGeAlD
Pazopanib—ABCB1—adrenal cortex—hypothyroidism	6.53e-05	0.000673	CbGeAlD
Pazopanib—ABCB1—heart—hypothyroidism	6.32e-05	0.000651	CbGeAlD
Pazopanib—CYP2D6—female gonad—hypothyroidism	6.11e-05	0.000629	CbGeAlD
Pazopanib—ABCB1—cardiovascular system—hypothyroidism	5.96e-05	0.000614	CbGeAlD
Pazopanib—CYP2D6—testis—hypothyroidism	5.42e-05	0.000558	CbGeAlD
Pazopanib—ABCB1—gonad—hypothyroidism	5.41e-05	0.000557	CbGeAlD
Pazopanib—ABCB1—pituitary gland—hypothyroidism	5.28e-05	0.000544	CbGeAlD
Pazopanib—CYP3A4—liver—hypothyroidism	5.21e-05	0.000536	CbGeAlD
Pazopanib—CYP2D6—liver—hypothyroidism	5.13e-05	0.000528	CbGeAlD
Pazopanib—CYP2D6—cerebellum—hypothyroidism	5.01e-05	0.000516	CbGeAlD
Pazopanib—ABCB1—adrenal gland—hypothyroidism	4.72e-05	0.000486	CbGeAlD
Pazopanib—ABCB1—blood—hypothyroidism	4.71e-05	0.000485	CbGeAlD
Pazopanib—ABCB1—thyroid gland—hypothyroidism	4.55e-05	0.000469	CbGeAlD
Pazopanib—ABCB1—female gonad—hypothyroidism	4.4e-05	0.000453	CbGeAlD
Pazopanib—ABCB1—testis—hypothyroidism	3.9e-05	0.000402	CbGeAlD
Pazopanib—ABCB1—liver—hypothyroidism	3.69e-05	0.00038	CbGeAlD
Pazopanib—ABCB1—cerebellum—hypothyroidism	3.6e-05	0.000371	CbGeAlD
Pazopanib—FGFR3—Signaling Pathways—CLTC—hypothyroidism	3.14e-05	0.000634	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CLTC—hypothyroidism	3.11e-05	0.000629	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CLTC—hypothyroidism	3.11e-05	0.000627	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—PRL—hypothyroidism	3.07e-05	0.00062	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—TPO—hypothyroidism	3.02e-05	0.000611	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ATP5O—hypothyroidism	2.98e-05	0.000601	CbGpPWpGaD
Pazopanib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.97e-05	0.000601	CbGpPWpGaD
Pazopanib—LYN—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.94e-05	0.000594	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—SH2B3—hypothyroidism	2.94e-05	0.000594	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—VAV3—hypothyroidism	2.85e-05	0.000576	CbGpPWpGaD
Pazopanib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.85e-05	0.000575	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—VAV3—hypothyroidism	2.84e-05	0.000574	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—SH2B3—hypothyroidism	2.82e-05	0.00057	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—PRL—hypothyroidism	2.81e-05	0.000567	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CLTC—hypothyroidism	2.81e-05	0.000567	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	2.8e-05	0.000566	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.8e-05	0.000566	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—TPO—hypothyroidism	2.8e-05	0.000565	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CLTC—hypothyroidism	2.8e-05	0.000565	CbGpPWpGaD
Pazopanib—LYN—Immune System—CLTC—hypothyroidism	2.74e-05	0.000553	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—AVP—hypothyroidism	2.74e-05	0.000553	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CLTC—hypothyroidism	2.74e-05	0.000553	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TRH—hypothyroidism	2.71e-05	0.000548	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—VAV3—hypothyroidism	2.7e-05	0.000546	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—POMC—hypothyroidism	2.67e-05	0.000539	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—VAV3—hypothyroidism	2.65e-05	0.000536	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—POMC—hypothyroidism	2.62e-05	0.00053	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CLTC—hypothyroidism	2.61e-05	0.000527	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—VAV3—hypothyroidism	2.6e-05	0.000525	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—IGF1—hypothyroidism	2.52e-05	0.00051	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—VAV3—hypothyroidism	2.52e-05	0.000509	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—VAV3—hypothyroidism	2.51e-05	0.000508	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—VAV3—hypothyroidism	2.51e-05	0.000507	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—AVP—hypothyroidism	2.5e-05	0.000506	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—PRL—hypothyroidism	2.47e-05	0.0005	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—VAV3—hypothyroidism	2.46e-05	0.000497	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TRH—hypothyroidism	2.43e-05	0.00049	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TSHB—hypothyroidism	2.42e-05	0.000489	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TSHR—hypothyroidism	2.42e-05	0.000489	CbGpPWpGaD
Pazopanib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.41e-05	0.000487	CbGpPWpGaD
Pazopanib—LCK—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.41e-05	0.000487	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TRH—hypothyroidism	2.36e-05	0.000478	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.32e-05	0.000469	CbGpPWpGaD
Pazopanib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.29e-05	0.000464	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—VAV3—hypothyroidism	2.29e-05	0.000462	CbGpPWpGaD
Pazopanib—FGFR3—Disease—PRL—hypothyroidism	2.28e-05	0.000462	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—VAV3—hypothyroidism	2.26e-05	0.000457	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TRH—hypothyroidism	2.26e-05	0.000456	CbGpPWpGaD
Pazopanib—LCK—Immune System—CLTC—hypothyroidism	2.24e-05	0.000454	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.24e-05	0.000452	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—VAV3—hypothyroidism	2.22e-05	0.000448	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—IYD—hypothyroidism	2.17e-05	0.000439	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TSHB—hypothyroidism	2.16e-05	0.000437	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TSHR—hypothyroidism	2.16e-05	0.000437	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CLTC—hypothyroidism	2.16e-05	0.000436	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—SH2B3—hypothyroidism	2.16e-05	0.000436	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CLTC—hypothyroidism	2.12e-05	0.000429	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TSHR—hypothyroidism	2.11e-05	0.000426	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TSHB—hypothyroidism	2.11e-05	0.000426	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—PRL—hypothyroidism	2.09e-05	0.000423	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.07e-05	0.000418	CbGpPWpGaD
Pazopanib—FGF1—Immune System—PRL—hypothyroidism	2.06e-05	0.000415	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—VAV3—hypothyroidism	2.02e-05	0.000408	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CLTC—hypothyroidism	2.01e-05	0.000407	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TSHB—hypothyroidism	2.01e-05	0.000406	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TSHR—hypothyroidism	2.01e-05	0.000406	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CLTC—hypothyroidism	2.01e-05	0.000406	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—VAV3—hypothyroidism	1.94e-05	0.000391	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—SH2B3—hypothyroidism	1.93e-05	0.000389	CbGpPWpGaD
Pazopanib—FGF1—Immune System—VAV3—hypothyroidism	1.9e-05	0.000384	CbGpPWpGaD
Pazopanib—FGF1—Disease—PRL—hypothyroidism	1.9e-05	0.000384	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—IYD—hypothyroidism	1.89e-05	0.000382	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—SH2B3—hypothyroidism	1.88e-05	0.000379	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TRH—hypothyroidism	1.87e-05	0.000377	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—AVP—hypothyroidism	1.87e-05	0.000377	CbGpPWpGaD
Pazopanib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.86e-05	0.000376	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ATP5O—hypothyroidism	1.85e-05	0.000373	CbGpPWpGaD
Pazopanib—CYP2C8—Biological oxidations—POMC—hypothyroidism	1.84e-05	0.000372	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TRH—hypothyroidism	1.83e-05	0.00037	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—POMC—hypothyroidism	1.82e-05	0.000367	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—VAV3—hypothyroidism	1.82e-05	0.000367	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CLTC—hypothyroidism	1.81e-05	0.000365	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—SH2B3—hypothyroidism	1.79e-05	0.000362	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—IYD—hypothyroidism	1.78e-05	0.00036	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CLTC—hypothyroidism	1.77e-05	0.000358	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.76e-05	0.000356	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—IGF1—hypothyroidism	1.75e-05	0.000353	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TRH—hypothyroidism	1.74e-05	0.000352	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TPO—hypothyroidism	1.74e-05	0.000351	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TRH—hypothyroidism	1.74e-05	0.000351	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—PRL—hypothyroidism	1.7e-05	0.000344	CbGpPWpGaD
Pazopanib—KIT—Immune System—PRL—hypothyroidism	1.67e-05	0.000338	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TSHR—hypothyroidism	1.66e-05	0.000336	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TSHB—hypothyroidism	1.66e-05	0.000336	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—POMC—hypothyroidism	1.66e-05	0.000336	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TSHB—hypothyroidism	1.63e-05	0.00033	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TSHR—hypothyroidism	1.63e-05	0.00033	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	1.63e-05	0.000329	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ATP5O—hypothyroidism	1.61e-05	0.000325	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.61e-05	0.000325	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—PRL—hypothyroidism	1.6e-05	0.000323	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—IGF1—hypothyroidism	1.6e-05	0.000323	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—PRL—hypothyroidism	1.59e-05	0.00032	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—PRL—hypothyroidism	1.58e-05	0.00032	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—VAV3—hypothyroidism	1.57e-05	0.000318	CbGpPWpGaD
Pazopanib—FGFR2—Disease—PRL—hypothyroidism	1.57e-05	0.000317	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TRH—hypothyroidism	1.56e-05	0.000316	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TSHB—hypothyroidism	1.55e-05	0.000313	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TSHR—hypothyroidism	1.55e-05	0.000313	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TSHB—hypothyroidism	1.55e-05	0.000313	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TSHR—hypothyroidism	1.55e-05	0.000313	CbGpPWpGaD
Pazopanib—KIT—Immune System—VAV3—hypothyroidism	1.55e-05	0.000312	CbGpPWpGaD
Pazopanib—KIT—Disease—PRL—hypothyroidism	1.54e-05	0.000312	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TRH—hypothyroidism	1.53e-05	0.000309	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—TSHB—hypothyroidism	1.53e-05	0.000308	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.52e-05	0.000306	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—IGF1—hypothyroidism	1.52e-05	0.000306	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TPO—hypothyroidism	1.51e-05	0.000306	CbGpPWpGaD
Pazopanib—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.51e-05	0.000305	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—IYD—hypothyroidism	1.51e-05	0.000305	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—SH2B3—hypothyroidism	1.48e-05	0.0003	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—VAV3—hypothyroidism	1.48e-05	0.000299	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—VAV3—hypothyroidism	1.47e-05	0.000296	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PRL—hypothyroidism	1.46e-05	0.000296	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—VAV3—hypothyroidism	1.46e-05	0.000296	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PRL—hypothyroidism	1.46e-05	0.000295	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—SH2B3—hypothyroidism	1.46e-05	0.000294	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CLTC—hypothyroidism	1.45e-05	0.000293	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PRL—hypothyroidism	1.43e-05	0.000289	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TPO—hypothyroidism	1.43e-05	0.000288	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AVP—hypothyroidism	1.43e-05	0.000288	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PRL—hypothyroidism	1.42e-05	0.000288	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	1.42e-05	0.000287	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.4e-05	0.000283	CbGpPWpGaD
Pazopanib—LYN—Immune System—PRL—hypothyroidism	1.4e-05	0.000282	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PRL—hypothyroidism	1.39e-05	0.000282	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TSHB—hypothyroidism	1.39e-05	0.000282	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TSHR—hypothyroidism	1.39e-05	0.000282	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—SH2B3—hypothyroidism	1.38e-05	0.000279	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—SH2B3—hypothyroidism	1.38e-05	0.000279	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TSHB—hypothyroidism	1.36e-05	0.000276	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TSHR—hypothyroidism	1.36e-05	0.000276	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PIK3C2A—hypothyroidism	1.36e-05	0.000275	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PRL—hypothyroidism	1.33e-05	0.000269	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VAV3—hypothyroidism	1.32e-05	0.000267	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—VAV3—hypothyroidism	1.32e-05	0.000266	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PRL—hypothyroidism	1.32e-05	0.000266	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—TSHB—hypothyroidism	1.3e-05	0.000262	CbGpPWpGaD
Pazopanib—LYN—Immune System—VAV3—hypothyroidism	1.29e-05	0.000261	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VAV3—hypothyroidism	1.29e-05	0.00026	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ATP5O—hypothyroidism	1.28e-05	0.00026	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—POMC—hypothyroidism	1.28e-05	0.000259	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AVP—hypothyroidism	1.27e-05	0.000257	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TRH—hypothyroidism	1.25e-05	0.000253	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.25e-05	0.000252	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—IGF1—hypothyroidism	1.24e-05	0.000251	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AVP—hypothyroidism	1.24e-05	0.000251	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SH2B3—hypothyroidism	1.24e-05	0.000251	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—POMC—hypothyroidism	1.24e-05	0.000251	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.23e-05	0.000249	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VAV3—hypothyroidism	1.23e-05	0.000248	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SH2B3—hypothyroidism	1.22e-05	0.000246	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TPO—hypothyroidism	1.21e-05	0.000244	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IGF1—hypothyroidism	1.19e-05	0.000241	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AVP—hypothyroidism	1.18e-05	0.000239	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—IYD—hypothyroidism	1.17e-05	0.000236	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	1.15e-05	0.000233	CbGpPWpGaD
Pazopanib—LCK—Immune System—PRL—hypothyroidism	1.14e-05	0.000231	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—SLC5A5—hypothyroidism	1.14e-05	0.000231	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.12e-05	0.000226	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.12e-05	0.000226	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TSHR—hypothyroidism	1.12e-05	0.000226	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TSHB—hypothyroidism	1.12e-05	0.000226	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PRL—hypothyroidism	1.1e-05	0.000222	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PRL—hypothyroidism	1.08e-05	0.000218	CbGpPWpGaD
Pazopanib—LCK—Immune System—VAV3—hypothyroidism	1.06e-05	0.000214	CbGpPWpGaD
Pazopanib—LCK—Disease—PRL—hypothyroidism	1.06e-05	0.000213	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.05e-05	0.000212	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PRL—hypothyroidism	1.03e-05	0.000207	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PRL—hypothyroidism	1.02e-05	0.000207	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VAV3—hypothyroidism	1.02e-05	0.000206	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VAV3—hypothyroidism	9.99e-06	0.000202	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SH2B3—hypothyroidism	9.97e-06	0.000201	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ATP5O—hypothyroidism	9.91e-06	0.0002	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—POMC—hypothyroidism	9.88e-06	0.0002	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AVP—hypothyroidism	9.8e-06	0.000198	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—SLC5A5—hypothyroidism	9.7e-06	0.000196	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AVP—hypothyroidism	9.63e-06	0.000195	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VAV3—hypothyroidism	9.48e-06	0.000192	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—POMC—hypothyroidism	9.47e-06	0.000191	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VAV3—hypothyroidism	9.46e-06	0.000191	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TPO—hypothyroidism	9.32e-06	0.000188	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PRL—hypothyroidism	9.21e-06	0.000186	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AVP—hypothyroidism	9.14e-06	0.000185	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AVP—hypothyroidism	9.11e-06	0.000184	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IGF1—hypothyroidism	9.11e-06	0.000184	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PRL—hypothyroidism	9.02e-06	0.000182	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	8.81e-06	0.000178	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VAV3—hypothyroidism	8.52e-06	0.000172	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—POMC—hypothyroidism	8.47e-06	0.000171	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VAV3—hypothyroidism	8.34e-06	0.000169	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—POMC—hypothyroidism	8.25e-06	0.000167	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AVP—hypothyroidism	8.21e-06	0.000166	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IGF1—hypothyroidism	8.15e-06	0.000165	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AVP—hypothyroidism	8.04e-06	0.000162	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TSHB—hypothyroidism	8.04e-06	0.000162	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IGF1—hypothyroidism	7.94e-06	0.00016	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—POMC—hypothyroidism	7.87e-06	0.000159	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IGF1—hypothyroidism	7.57e-06	0.000153	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PRL—hypothyroidism	7.39e-06	0.000149	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	7.17e-06	0.000145	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.07e-06	0.000143	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TSHB—hypothyroidism	7e-06	0.000142	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VAV3—hypothyroidism	6.84e-06	0.000138	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TSHB—hypothyroidism	6.6e-06	0.000133	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AVP—hypothyroidism	6.59e-06	0.000133	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—POMC—hypothyroidism	6.52e-06	0.000132	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—POMC—hypothyroidism	6.4e-06	0.000129	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IGF1—hypothyroidism	6.27e-06	0.000127	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	6.24e-06	0.000126	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IGF1—hypothyroidism	6.15e-06	0.000124	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—POMC—hypothyroidism	6.07e-06	0.000123	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—POMC—hypothyroidism	6.06e-06	0.000122	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SLC5A5—hypothyroidism	6.02e-06	0.000122	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—POMC—hypothyroidism	5.98e-06	0.000121	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	5.88e-06	0.000119	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IGF1—hypothyroidism	5.84e-06	0.000118	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IGF1—hypothyroidism	5.83e-06	0.000118	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TSHB—hypothyroidism	5.59e-06	0.000113	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—POMC—hypothyroidism	5.48e-06	0.000111	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—POMC—hypothyroidism	5.46e-06	0.00011	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—hypothyroidism	5.34e-06	0.000108	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IGF1—hypothyroidism	5.25e-06	0.000106	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SLC5A5—hypothyroidism	5.24e-06	0.000106	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IGF1—hypothyroidism	5.14e-06	0.000104	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—hypothyroidism	5.07e-06	0.000103	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	4.98e-06	0.000101	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SLC5A5—hypothyroidism	4.94e-06	9.98e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.92e-06	9.94e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—hypothyroidism	4.38e-06	8.85e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TSHB—hypothyroidism	4.31e-06	8.72e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IGF1—hypothyroidism	4.21e-06	8.51e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC5A5—hypothyroidism	4.19e-06	8.46e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.85e-06	7.77e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.23e-06	6.53e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—hypothyroidism	3.15e-06	6.36e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—hypothyroidism	2.74e-06	5.54e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—hypothyroidism	2.58e-06	5.22e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—hypothyroidism	2.19e-06	4.42e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—hypothyroidism	1.69e-06	3.41e-05	CbGpPWpGaD
